Mira, founded by Sylvia Kang, is a pioneering women’s health company that offers at-home hormone tracking to empower users through continuous, personalized data. Addressing unexplained infertility and the lack of accessible, actionable information, Mira provides real-time insights into key hormones like estrogen, progesterone, FSH, and others—offering a far more comprehensive view than traditional ovulation kits. The company has built one of the world’s largest continuous hormone datasets, which fuels critical research into hormone-symptom links, particularly in PCOS and menopause. Users gain control over their health through tailored action plans, community support, and direct access to coaching and AI assistance. Mira’s growth is driven by strong consumer demand and word-of-mouth adoption among women navigating fertility and life-stage transitions. The company is expanding beyond fertility into full-spectrum women’s wellness, with plans to integrate hormone monitoring into broader health routines and clinical care. Through partnerships with researchers, doctors, and employers, Mira aims to democratize personalized healthcare and influence medical standards. Its upcoming Ultra-Fort test offers a faster, more accurate, single-hormone kit using advanced lab technology. With a clear vision to become a central platform for women’s health across life stages, Mira combines innovation, data, and community to transform how women understand and manage their bodies.
about one third of the infertility has been diagnosed as unexplained infertility which means
you might have something wrong but I don't know what is that so you deal that with by yourself
but the consumer is not happy with those answers, consumers are looking for something I could do
so I have more control, I understand what this is and I have an action plan and by doing this action
plan and I can feel better, I can become better so that's what it is here that's pretty trying to look
for. Welcome back to the Fidence Outer Podcast, I'm your host Joven Henry. Today I'm joined by Sylvia
Kang co-founder and CEO Mira. In this episode we discuss Mira's mission to reinvent women's hormone
health. Sylvia explains how Mira is at home hormone tracker is closing clinical gaps and empowering
women at every stage of life. Plus we talk about building a community first platform and reimagining
personalized care for fertility, menopause and beyond. Let's get into it. The Fidence Outer Podcast
is presented by EGIM. EGIM's smart fitness ecosystem is transforming healthcare through exercise
combining strength equipment with AI powered software and corporate wellness platform
well pass it's leading the shift to proactive preventative health. Learn more about EGIM's intelligent
workout solutions at eGIM.com. Hi Sylvia, welcome to Fidence Outer, thanks for joining us.
Hi Jo, nice to meet you here. The kick things off, I was hoping you could just introduce yourself
and tell us about Mira and then we'll kind of jump into the conversation. Sure, so my name is Sylvia,
I'm the CEO and co-founder of Mira. For my background I was born in China and I actually started
as a professional pianist. I started playing while I was four and my mom really wants to be,
want me to be a pianist because in the Asian culture and this thing the girl shouldn't be fighting
for some things that's very difficult like technology or science. But in my high school years,
I realized I really love science so I self studied all the science classes because I went to a
conservatory which doesn't offer any science classes. I came to the US, I did a master in biomedical
engineering from Columbia and then followed by MBA from Cornell and then I was working in a
Fortune 500 life science company. I was managing a 100 million dollars of global P&L as a business
director and then I started Mira. And the reason I started Mira is because I realized that many
women friends, like my friends, they were starting the family and they were about 30 years old,
there was little help given to them. We never had any education about the fertility and then when
we're trying to start a family, we feel like it's just not as easy as we thought. So we either
were using this ovulation predictor kit which is one line versus two line is very trivial,
it's like a last century technology or we've been sent to IVF after half a year being not successful
and which is like 30,000 dollars out of pocket cost per person per cycle. So there's definitely a gap
in between. You know, we don't, as a consumer, we don't understand our body and we feel anxious,
we feel stressed out and on the doctor's side, they also don't really know how to read the hormone
data. So I think I think we really need to change that. So I have my whole founder which is a
technical guy and we started this company in 2017. Yeah, that's an incredible story and journey
from another country in a pianist to to starting this company. I think there's a lot to get into
there but first just so people have a sense of their, if they're not familiar, there's the kind of
hormone tracking kit that you mentioned, there's the app, there's the coaching like what all does Mira
entail and then we'll, you know, get into some of the details. Yeah, sure. So Mira is the hormone
tracking device for you to use at home. So we sell directly to consumer and we track most of the
female hormones like outage, estrogen, progesterone, FSH and then we have more hormones in the pipeline
in the future. So what we do is like we give you a quantitative reading about your hormone number
at the time. So just imagine you're taking the lab test which is blood joint and you cannot
get a continuous monitoring but with Mira, you can easily do that at home with your urine sample.
So in end of the day that will be transferred to our app and on the app with your data interpretation,
there's a plot for you insights and also if you choose to talk with our, you know, AI assistant and
you can do that and you can also talk with our coaches, we have a small team there for to coach
professional providers and they can answer your question. So we mostly help people trying to
conceive and going through menopause, manage irregular cycles or anything you have a concern
about your hormone profile and it will help people directly do this. And on the other side,
we also help doctors to have a better understanding about their patients hormone cycle so they can
improve their treatment outcome. Yeah, I'd be curious to hear like starting in 2017 and then
growing the company now there's and continues to be more momentum around women's health in general,
hormone tracking, all in doing these things at home kind of for the end user. As you conceive of
this idea, you're starting to get it off the ground like what type of reception was there, was
there a lot of interest? Did you have to do a lot from whether it was consumers or investors or
just the market in general to really educate people about what you were trying to do? Yeah, absolutely.
So that was definitely an uphill battle. So when I started in 2017, there was no such an industry
called a women's house. There's no such a concept. So we were trying to raise money and we couldn't
really say, you know, we couldn't really articulate what we do. So we have to say, oh, we are IOT
home testing device or like IVD industry and someone said, oh, you're hardware, you're consumer
business. So it's very difficult to find any investor who are interested specifically in this
industry. And also when I was raising money, I had a lot of male investor and that was a difficult
conversation too. I mean, they don't really understand how hormone works and it took a lot of
time to educate them become more like a biology one oh one those kind of conversation. So obviously,
it doesn't turn out to be very good. And also I was collecting feedback from the doctor side.
Absolutely, there's some, you know, doctors who are really passionate about, you know, moving forward
with this personalized the house, but so ever. But at that time, it's kind of rare. So I talk with
a doctor introduced a OB doctor introduced by my friend. And she said that I don't want to this
device because it's given my patients too much data. I don't want them to know they don't understand.
They're going to ask me so many questions and they increase my workload. They're just going to
cost more confusion. I would hate such a device to go to market. That was exactly what
she gave to me. But, you know, when we look at the consumer side, it's really different story.
Because obviously you can tell, right? So we're 21st century. We're trying to send people to
Mars and Rocky to Mars. And from women's house, such an important thing. We're looking at this paper.
And I look at a consumer, what they do is they test the test strip every day and they want to track it.
So they put on the have a paper and they put down these strips line by line, you know, line up
over there. And then send this picture to somewhere like a Reddit to say, hey, please take a look.
Am I really ovulating on this day or not? It's my line dark enough and the light enough
and other women were trying to help them. So obviously, you can totally tell such a strong
pain points over there. And then we, you know, we decide to go to the consumer way. And obviously,
I think the consumer is a good sense that our consumer did understand what formal means to them.
And they're putting for this. So I think that's also why our sales was able to scale up quite quickly.
Yeah, I was going to ask if you have a sense of what you attribute the success and resonating
in growth to because I mentioned to you before we started recording that my wife used Mira and
she heard about it basically through word of mouth. Like there's, you know, a group of young moms
and they all kind of have the checklist of, hey, what do you need and what should you use when you
start thinking about it? And every single time Mira would come up. And so that was one of the things
obviously that we were what to use. And our son is going to be nine months old. So clearly,
it worked and helped a ton. And that there was so much just passion. It seems like the wrong word
to attribute to, you know, like a hormone tracking device and like you're an analysis, the passion
behind it. But really, that's what it was. Did you try to do that? Did you, did you set out to
instill that type of relationship? How have you fostered the kind of community that you might not
associate with like a hardware product necessary or a medical device, right? Yeah. Absolutely.
So I didn't really prepare for that. So when I started, I was just my motivation was really simple.
I saw there's a pain point. So let's do something. And I did the market research. I found there's no
other, almost no other so called a women's house company. So, you know, everything's pretty general.
So I said, well, here's a gap, right? Here's a pain point. So let's foster that. But when we start
to, you know, develop the product and go to market, I personally, I learned so much. I didn't know
women had so many problems or until today still have so many problems going into their regular life.
It's not like, oh, this is like a rare disease. Only one person and women will get that.
So almost everyone going through this fertility journey, pregnancy, postpartum,
perimenopause, but so ever will have some problem. And the usually 90% of the chances problem
doesn't have an answer. So that's where the motivation came from, you know, for our consumer to
form a community. So that's why you see the consumer behavior, like our user behavior, say,
there's a word of mouth. I'm trying to help you. I'm trying to form a community so we can discuss
about all these things. So, you know, just some example in there, like we had users who had
the really irregular cycle. And this is probably even PCOS. It's like a 15%
of global population for women, and there's a reproductive age right now. So that's so popular,
but there's no cure, and there's no even no good self-management tool. Just see, PCOS persons,
you want to get pregnant until today, there is no product at all that can truly solve this.
Maybe there's some product trying to help you to track your cycle, but it doesn't really help you
to tell like when is my ovulation time, for example, and also menopause is another super underserved segment
and used to be a taboo for tedious to be taboo. We don't have tools and we cannot even talk about this.
It's not good to talk about this somehow. We have users going to a perimenopause and it's a long
time journey. Not everyone's comfortable with going to a hormone replacement therapy HRT immediately.
So that suffering time is probably like a nine years, seven, nine years, eight, nine years before
they have any official treatment, but during those years they suffer from half-slash and you know,
brim fog, a factor of their daily life, and in Sonya, someone cannot even sleep continuously
for like a week, like totally could happen. And they go to a doctor and doctors say, "Well,
this is just part of your life. Just relax. There's this normal. There's nothing you could do.
Same thing as fertility. About one third of the infertility has been diagnosed as unexplained
infertility, which means that you might have something wrong, but I don't know what is that.
So you deal that with by yourself. But the consumer is not happy with those answers.
Consumers are looking for something I could do, so I have more control. I understand what this is,
and I have an action plan. And by doing this action plan, and I can feel better, I can become better.
So that's what they're desperately trying to look for. And they look at the entire women's house
stage, you know, from puberty until menopause. Almost every five years, they're going through
different stages. They always have questions like that, but there's always no problem to solve this.
And the doctor is really not the best resource to get that information. So we will go to Google,
we will go to chargeivity. That's why you saw this community. And when Mira came out,
here you go. So there is the not only a product, but this product is not only a tester. It's more
like we're trying to provide our users with a solution. And this solution includes emotional support,
community, somewhere that can freely talk about this. It's no longer a taboo. And our brand
story really trying to voices. I personally tried everywhere I go. I tried to say, women's house is
not the niche. We are 50% of global population. How come we just, you know, a few years ago,
we just still think that's the niche. It's not correct. There are so many underserved problems,
whatsoever. So we're trying to help with the problem, with the product, and with the brand
story. There's basically, there's a, you know, spirit or like a motivation behind what we're doing.
And obviously at the same time, we're trying to connect our industry, not only on the consumer side,
but trying to educate doctors. You know, doctors now change the lot. There are many doctors working
with us. They're very open to personalized medicine, to democratize healthcare. So it's very
different from many years ago. So all this thing has to work together. You want to make some change.
Clearly, it's to my point, just the word of mouth and the passion. It's working. And then also,
to your point, there's still so much more that can be done. When you think of, you know, now
there is this momentum behind women's health, but even even that is like, it's kind of a catch-all,
right? There's so many different things within that. There's hormones and fertility and all
these different things, menopause. And now you're starting to have fertility, to hormone clinics,
to IVF, to longevity, to preventative health. Have you or how are you starting to think about,
hey, how do we make inroads into these different areas? How do we continue to help inform
not just users, not just doctors, but just like this industry, this category with like,
these are the different use cases. This is how this information can be put to use. And then,
in many ways, mirror is kind of the intersection of all that.
Yeah, exactly. So that goes to really from a women's house to more like a wellness management as
well. I think that's a very good point. I always said that our body is never being in isolated
scene. Your body is a housing. So what your hormone does on this today, and there's longitudinal
is I will affect something might happen a few years ago. And also, your lifestyle, your wellness,
will all go into play into like a stress, for example, will all go into like a how your fertility
will turn out to be what kind of symptoms are going to have in a few years if you're going to
prevent a positive or so on. So I think to answer the question, I think we really need something
more comprehensive. And this comprehensive solution could be coming from a multiple companies
working on the problem together, because you see now there's like we're testing company,
and there's a more like some virtual clinical company, and there's software whatsoever. And also
could be, you know, some company growing much bigger. Like, for example, mirror does have
the vision to go more or let's say we launched more test ones, and we can test more hormones going
into wellness and taking into consideration of more hormones and say how they would affect
the fertility. So both routes are possible. I see companies are doing this, but also, you know,
just another dimension on this is like, it's not only a product innovation. There's many things
need to happen behind the product innovation. For example, once in a research, like a women's
health research data is so lacking, we're not even included into the clinical trial until very
recent, like probably 20 years ago. There's really lack of understanding, you know, like when a startup
company trying to disrupt this market, we need to know what is the science behind that, but not
rarely, you know, since that happened, at least on the consumer side. So that means a lot of research
more needs to happen. Understand, for example, everyone's suffering through mental pals and about
this, you know, symptom, but what is really the root cause for the symptom is that the hormone
change is something else. And by changing our lifestyle, or how that could correlate with
the improvement of our feeding or symptom like that, all this will need the longitudinal data,
we'll need like a continuous tracking, and we need time and funding to go in there to do research.
And the product will come out based on this research, and that will be truly working. So still,
I think it's going to take some time, but I see, you know, a lot of good companies are working towards
that. And obviously, the mirror is working towards that too. There is this shift that happens when
at the heart, right, you mentioned basically medical device biology, like all these things that are
being infused into this product that then goes to the consumer route. You start to gain users
and growth and momentum, and you're impacting the health and wellness of many, many people,
and that compounds, and that compounds in the data set. So you have the data set, and then you
improve the product, you improve user outcomes, it drives it forward. But then there's this next step
of like, how do we do the R&D? How do we fuel it? How do we take it to the next level? And there
are companies to your point that have started to do this. Do you see that as like a focal point?
Like, hey, we are going to now mirror, participate in, or maybe already doing this,
clinical trials or studies or just publishing research to really drive this industry forward. And
in some ways, it's you become then responsible for funding these things that are reshaping just how
people think about health and well-being. We're already doing this, and I recently
you mentioned pretty much we're doing that. So we have today, we have 27 million continuous
hormone data. I don't have anything to prove this statement, but I believe this is the biggest
continuous hormone data set for women in the world, because no study has never been done
like that before. And I did research a lot of paper on path med, or so on. Since the lack of
women's health research, I've never found any, you know, very solid, very well-defined study
about the continuous hormone data for women. So yes, so we do a lot of research right now,
and we research about, as I mentioned, like the correlation between the symptom and the hormone
fluctuation on menopause. And we also research about how lifestyle change will improve your
fertility, what kind of things will affect it that, like for example, this age really also,
it's a traditional saying, oh, once you pass the age 35, you cannot get pregnant, you have to go
through IVF. I don't think that's really true. Just like everyone should have 28, 28 days cycle,
that's never been true. That is average, average means almost 50% people are boxer and 50%
people are below that. So what is really this personalized pattern and the information and the
science and the data we can use? So yes, we're doing a lot of research on that. And obviously we have
our own focus, and we want to provide consumer, our number one goal is to provide the consumer with
more like a breakthrough solution. It's not only just the product. So let's say we can, one way to
go is like we test, we try to test the more hormone, so we have more comprehensive pictures
about how women's health will look like. But at the same time, you know, when we have this data,
what can we fit back to them? As you said, this 20 million data, what does that mean? What is
a pattern? What is a tax? We can apply to there. And then next, the woman come to our platform,
and they say, okay, I say, serving you a little bit, you have this kind of character. And then we know,
your relationship, your, you know, symptom whatsoever is likely to work in certain way, or certain
treatment plan, certain wellness, like fitness or stress release plan, we'll likely to work for you.
So that's our goal. And we're also doing a lot of partnership with more like a fundamental
research, like we have partnership with universities about like a pattern of PCS hormones.
So that's also been a miss.
So many PCOS patients in the world,
we never had a really clear understanding
about how there's a real pattern
for each type of PCOS.
There's four types of main PCOS.
And how can we have a treatment
for some like to relive the same time
to mix and feel better?
We never had that.
Yeah, so there's many,
and also we have some research about IVF.
You know, how do we reduce the cost about IVF?
We probably don't need to really go to blood drawing all the time
if they can test with mirror.
And the doctor can see the hormone profile
about responses to the hormone stimulation
continuously from a mirror back end.
So that's, you know, definitely will help
to improve the treatment outcome
and also reduce your cost.
Your nurse don't have to cause the patients
everything to stay healthy.
How dark is that line?
Are you really close to ovulation?
If you schedule right now, don't get too late.
So that will save a lot of costs in there.
So I'm a strong believer in the research in the data.
We are doing a lot of them.
And some can be done by startup companies like us.
And some maybe still need a single bigger,
you know, government funding or so on.
We rarely got that too in women's house,
but it's moving forward.
- This episode of the Fit and Sider podcast
is brought to you by EGEM.
EGEM makes some of the most innovative
strength training machines on the market.
But it's only one part of their integrated ecosystem.
With connected fitness equipment,
AI powered gym software,
and a comprehensive corporate wellness offering,
it's forging the future of preventative health.
Partnering with companies worldwide,
EGEM's well-passed program improves employee health
by expanding access to premiere fitness
and health facilities.
Upgrading gym floors,
EGEM equips every operator with smart equipment
and AI tools to create hyper personalized training plans
for every exercise.
Putting it all together,
they're transforming healthcare through exercise.
Experience the power of EGEM's ecosystem at EGEM.com.
- It's such a powerful flywheel for a company,
especially a consumer health wellness company,
and then in women's health to be able to say,
hey, we're essentially spearheading all of this
in our product, our community,
our data is driving this forward.
And yeah, if you have partners
and government funding and all that,
but then you just take that and like you said,
pour it back into the solution
and makes it even more powerful.
So I think it's something that it's difficult
for a company to start out saying,
like, oh, that's the playbook.
Like, that's how we're gonna do it
because so much has to go right to get there,
but when it does the defensible, powerful, compounding,
like all those words come to mind,
when you think about the kind of landscape,
you know, more kind of attention is good, right?
A lot of rising tide lifts all boats.
And so you have more people focusing on women's health
and also hormone.
But then there's also a number of,
you know, whether it's a wearable device or saliva
or subcutaneous like monitoring.
Do you think about that as competition?
Do you think about one being better than the other
or how you differentiate in that landscape?
Like, where does your mind go?
- Yeah, I think it's a must.
It's neat.
Actually, a lot of them is like,
there's different segments for a different use case.
Like, for example, variable, right?
We can just use example for continuous glucose monitoring
versus glucose major.
So they both have their market segment
because they serve different purposes.
And also I say that as the timing as well,
so usually people, let's say hormone
is a little bit behind the glucose.
I think glucose awareness, everyone knows
or whether I need to track or someone,
hormone is more on the earlier stage
and in that the curve of the customer understanding
or market understanding.
So usually that will start from some tests,
like a daily test whatsoever.
Like a urine test, saliva test whatsoever.
But after a while,
when the consumer awareness has been developed
or a market awareness has been developed
and there's clearly defined a use case
about what the continuous hormone monitoring will do.
And that is definitely needed.
I think there's a market for that.
And for now, are we ready for that?
I don't think there's a market ready for that.
Maybe gonna be five years,
maybe gonna be a little bit longer.
And also there's a different segments in there too.
For example, we work with a lot of integrative medicine doctors
and many of them are talking about this.
They like this.
They want to say they continue to hormone curve
and they want to say what they can do with that.
So that may be some already adopter over there.
But if you go to general consumer,
it depends on how you design the products.
Maybe it's not there yet.
It's like a consumer's want to understand
to say, okay, why do I need to track my hormone?
You'll stick this in my arm for so many years.
But I see them as the,
there's definitely a different diversity in there.
Some will come earlier, some will come later.
I see them as pretty good.
I mean, it's moving the industry forward.
And also for the mirror portfolio,
mirror is not a static company.
We're always evolving.
So it doesn't mean we're not gonna get into there.
Maybe one day we're gonna get into there,
but we have our own strategy.
You know, we don't do every product in the world,
but we have our view about how women's health
work, like at least the hormone testing.
As I said, the hormone testing just one thing
has to be combined with the solution
and the very clear use case.
And how that could evolve for us as a landscape.
We have a planning over there.
We may get into some areas you mentioned.
So yeah, I think it's a good thing.
You know, there's more player here.
And then women's health become like more people talking
about this and get more attention
from investor from funding side as well.
- Yeah, you're stressing this idea about
the specific use cases and then having a solution
tied to that.
How do you make it so that you're connecting this data
in the monitoring two solutions
that actually, you know, deliver some type
of behavior change?
- Yeah.
I think the first thing you have to find the use case,
there's always some use case.
It may be hidden.
It's because we never had a product before.
But I believe you cannot.
You don't wanna start with something
that deserves absolutely no porting from the market.
For example, you can imagine that the,
let's say in IVF, right?
So there are many people don't wanna draw the blood
to test the hormone every day.
So that's a clear pinpoint.
But obviously, you know, the how strong that is
and what would be the perfect product over there,
we have to, you know, design and to think about that.
But there is a clear understanding.
I see there's many cases.
And for example, and other cases like PCOS ovulation.
So as I mentioned, there's really nothing
can be done over there today.
There's products claiming I can track for PCOS,
but they cannot predict the PCOS ovulation
because that's so complicated.
Well, I have irregular cycle.
Maybe I need to test them more often.
Then I have regular cycle.
So that the testing frequency needs is very strong.
And especially you can imagine
there's sub-segment in PCOS.
They're trying to come safe.
So that's a very strong, like a specific requirements.
Or like some people go into perimenopause,
they have irregular cycle.
And as they want to feel better,
they just want to get the sleep pattern better,
sleep more regularly.
Or they just try to understand what they did the night before
and they will tend to have hot flash.
I'm just making this up.
But those are all consumer legit, consumer questions.
We can research which one will be a higher percentage,
major consumer questions question, where's the minor.
But you can tell there's many micro-pinpoints there
that either your kinds could be doctor,
could be patients already pulling for that.
So usually we start from those kind of cases,
but we expand from there.
And when you go in there, you will realize that,
well, here is the customer question.
But the actual business model is a evolution
out from the customer question.
If you only address the customer question,
you will die over there.
You just have a little bit here.
And you say, oh, it's not scalable.
It's not gonna become business model.
What they're gonna do next?
You hit the wall and you kill this idea.
So that's not how it should be.
But once you start to have the entry point in there,
and you can start to expand.
Let's say this PCOS situation, right?
So someone wants to track it more often.
See, every day, I want to track it.
I want to understand from a pattern
about my hormone, okay, they start to track.
And then you can start to give them a guidance,
give the data and give them what they could do.
And that needs to be based on research.
Research can be launched using the research
based on the data based on the pattern.
And then say, here's my suggestion for you.
And they collect their feedback and whatsoever.
And along the way, you will also hear customer feedback
and say, how do I like this solution?
I want to have a little bit more.
I want to talk to a person.
I have probably there's different segments too.
I really stress out.
I just need to therapist.
Okay, therapist angle.
And I want to talk with a doctor.
And here's a doctor angle.
You can send patients to doctor.
Or I just want to have more content,
personalized content on the app.
Or someone just want to have a routine.
A routine is very helpful.
Maybe because maybe if, let's imagine,
you eat really healthy, you try to sleep well,
try to keep the sleep hygiene.
You keep your time for exercising or meditation every day.
Of course, you're going to feel better, right?
So, but it's very difficult to do.
So maybe the people just need the app
to really help them to follow this routine.
So you will say, you know, from this single point about,
I just want to track my hormone more.
I just want to understand myself more.
Actually, this can derive into many different passes.
And then it's a company decision about
what is a product I'm going to be or the which pass I'm going to take.
So that kind of breach, you know, from here is a very,
you know, rough idea about, you know, pain points.
I was talking about this.
Everyone never figured out the solution.
For example, menopause management until to be,
okay, now I know what as a company,
what I can physically build.
For short term, for long term, both will make sense.
So that's kind of how we usually work.
It takes time and especially, you know, for Mira,
we're really like a pioneer in women's house.
Let me tell you this steel is a young industry.
So it's different from like a software says there's really company being like in a say 500 million
dollars revenue yet. So mirror has been a pioneer over there. So we're kind of shaping this. We're
trying and we're trying to explore different models trying to educate the consumer. But we do say
there's a feedback from the market too. You know when we educate our consumer, they want it. They do
want that. They pay and they they want it. So it's a viable pass to move forward. And when we talk
with some doctors and they also want it too. So there are needs from the market. We capture those
needs, find the easiest and the most clear penetration point and then trying to expand from there
and trying to build the industry. And I think if we could be successful more investors and the
latest, like I mean earlier stage companies will look at us to say here might be some role model
and that could be you know inspirational and more findings could go to miss house.
We get towards end of the conversation, maybe just a couple more questions. One kind of down
that path of you know, as you see this category evolving, you kind of alluded to this earlier,
whether it's like, Hey, do we partner and integrate or do we build kind of this full stack
solution and think about how we address these different not just stages of life and conditions,
but just kind of needs across the spectrum. As you look at like the broader women's health
category, if we want to call it that, there does seem to be companies that they, you know,
get funded, they emerge, right? They start getting their footing and they're tackling something
that's pretty narrow. Like there's like one problem or maybe a specific problem. And then over time,
really, maybe they get acquired or they have to kind of expand into this longitudinal care kind
of platform and you know, what does that look like? So it goes from this thing, this is in some
ways like the hymn story hymns started as like, Hey, we're going to do ED for men and we're going
to do hair loss. And then it's like, Oh, really, we kind of have to do everything. If we're going to
be a, you know, venture backed multi billion dollar company, do you have a perspective on, you
know, it sounds like you're, you know, at the place where it's like mirror is going to continue
to stay focused. And we have a roadmap and we have goals. But do you have like a ones better than
the other? Or you are more leaning towards, Hey, we want to build this full stack solution and
have a path to doing that. What does that look like for you? Yeah, we want to be the later one.
We want to build a full stack solution. So I think it's a very natural pass. I have observed
and talked with many startup companies and the unit company has to start with something very
specific because you have to be focused already stage. You don't have resource. You have
limited resource and you want to solve a very clearly defined pain point. So you can get your revenue
and the team can be running. You can be profitable whatsoever. You can raise money whatsoever.
But after that, yes, after certain time, you have to expand. So that's definitely our,
our vision and our ambition. You know, we want to solve the women's house problem. We want to go
to multiple stages for women's house. We started from trying to conceive. Now we're already in
men's house. It's doing quite well. And we think a record cycle will be really interesting. We think
postpartum will be really interesting. So that's on the application perspective. And also,
we want to test more hormones, as I mentioned, you can imagine, you know, there is the, uh,
for like a home testing. There's already well. There's other, you know, lab tests, the companies.
There are many out there. If you go to Amazon, everyone has like a hundreds of biomarkers to test.
Why can't we do that for women's house at home? If you look at the biomarkers, you will say
many of them, we need a continuous testing. We never did that because we don't have that technology.
Doesn't mean people don't need this. Many hormones will change every day. For example, cortisol,
right? So that changed. You can test it even four times per day in the morning, afternoon,
uh, the before you go to sleep is all different. And they have different meaning. And the test
software doesn't change that often. But also if you combine with some other hormones, that's pretty
interesting too. You can understand that if your PCS is getting better and you have too much
endrogyms that might cause the acne and factor skin condition whatsoever. So even just within
women's house, there's much more than just the usual fertility hormones we test. So if we
incorporate, you know, hormones like this, you can go further. For example, ketone. So that's also
about the metabolism, right? So that's going into wellness about how your lifestyle is and the,
how does that affect your body? If you combine all this data, you can absolutely find something.
For sure, finally, for the company itself, for research purpose, for our consumer, as a feedback
to them, as a feature, and to the doctors, and doctors can devolve protocol, can, you know,
incorporate the mirror into zero protocol and become a part of the practitioner standard as well.
And in our healthcare industry, also there's another one which is a payer. So unfortunately,
for fertility, as never being covered by insurance, which is kind of crazy to me because I guess
it's like a reason is because lack of research is not being diagnosed as a disease. But it's true,
you know, fertility is a combination might be a combination of many problems. Maybe you're too
stressed out so you cannot get pregnant. But obviously it's not like, oh, here's a cancer. You can
say it. There's a cure tumor. So the insurance will cover that. So that needs more data. But good
seems like right now, there's employer benefits program and covering that. So Mary is now covered by
carotomywin, winfertility, you know, all this major employer benefit program already. And we're
working towards others, not only about our device, but the entire solution to gather with our
virtual clinic or so on. So you see, there's many directions we're trying to go. So our ambitions,
like we want to really become the women's health testing platform. So not just for your one stage,
for your entire life. Maybe your mom can test the daughter can test the grandma can test as well
at the same time. And also we have all the data. So we have most of data from you and then we can
tell you what to do. And we will also connect with your doctor, help you at least help you to talk
with your doctor better. That's actually a very legit customer ask based on our understanding.
You know, they just want to talk with your OB. Obviously, kind of don't understand. They say I have
the same time, but obviously I don't see that in your test results. I just ignore that. So they
want to have a better conversation. And we can also influence some doctors on the side. And like
Integrity Medicine doctor is our first try, you know, on the be to be on the provider side.
It's been going really well. And we try to work with insurance company as well. So basically,
we're trying to integrate this personalized home testing for women's house across many stages
into a standard into our house care right now. It's totally not. I know that's a very ambitious
goal. But you know, we have started by start plan to get into there. Also, I'm a very,
you know, I'm a very open-minded person. So I don't really say, oh, competitors, ABC or you guys,
you know, shouldn't be here. It's just our market. I would say that in certain ways that you do
need to have multiple prayers in one segment. That's a very good signal to the funding, to the
investor, to some doctor, to others, you know, be to be industry. This segment does have
opportunity. It's growing. And the people trying different ways. There are opportunities there.
And if some company can come out to be here to be very successful to, you know,
access with a good value or revenue growing really well, well, that's building more confidence as well.
So actually, it won't really come back to benefit ourselves. As you put that plan into action,
maybe there's nothing that you can tease right now. You keep everything under wraps. Is there
anything that we should look out for that you're particularly excited about? Just give people
something to be top of mind? Yeah, sure. So we're launching a new product, very soon, in August,
so which is called ultra-fort, has the land. And ultra-fort means the four hormones to gather our
age messaging, progesterone, and the FSH. So all the same test ones. So it will be very easy to
test. And this will be your go-to test one. You only need the single test one. And this is the
newest generation of technology as well. It's not only combined four together. So it only takes
much shorter time than we currently take on the mirror analyzer. It's following the same technology
of immunoforescence, which is a lab test. The technology is different than anything else on the
market by, you know, viewing this one line versus two line or using the camera, phone camera,
to take a picture of one line versus two line. Actually, eventually, it's the same input is the same.
So it's very different from that. And we also improve the many things about our want designs,
easier to use. And there's more accurate. We have data to, you know, to back up that. So this
will be, I would say this is the most advanced consumer fertility or hormone test product on the
market. And it's coming up in, in August. And now it's pre-order. If anyone's interested,
they can find that on our website. Yeah. And wrapping up there, where can people learn more
the website, social news that are anything you want them to follow along with. Sure, sure. So they
can go to our website, which is miracare.com, m-i-r-a-c-a-r-e.com. And they can sign up for our newsletter.
We have really exciting content in there. We offer free webbing now all the time. We are actually
organizing our own podcasts. And that also will be free. That thing is going to go to, you know, Apple
podcasts. They can find there too. And they Spotify as well. You can also find out as on any social media
platform. Just search mirror fertility is one word, no space. Any social media like IG and the
Facebook or you're on TikTok, you know, Pinterest, whatever is all on there. Yeah. So YouTube as well.
Also, you know, just.
I would really encourage people who are interested in women's health.
We're passionate about women's health, we're passionate about fertility,
men's health, where you're facing some personal challenges to follow us.
Because there are so much free content in there.
And then something should be for sure going to be helpful for you.
Perfect.
We will make sure everything is easy to find and links the show notes.
And so grateful that you made some time for us today.
Thanks so much.
Sherry, thank you so much, you.
Thanks for listening to today's episode.
If you got value from the conversation, please consider subscribing and sharing the
podcast with a friend or colleague.
It's a massive help.
And if you want more content like this, including news and insights on the latest
industry developments, subscribe to the Fit Insider newsletter at insider.fit.co.
And one more thing you can learn more about our recruiting and consulting services at fit.co.
That's F I T T dot CEO.
I'll see you here next week.
(upbeat music)
Podcast Summary
Key Points:
Mira addresses unexplained infertility and women’s hormone health by offering at-home, continuous hormone tracking with accurate, real-time data.
The platform empowers users with actionable insights, emotional support, and a community to manage fertility, menopause, and irregular cycles more effectively.
Mira’s data collection represents one of the largest continuous hormone datasets for women globally, enabling breakthrough research on hormone-symptom correlations.
The company focuses on solving specific, consumer-driven pain points—like PCOS ovulation timing or menopause symptoms—before expanding into broader wellness and longitudinal care.
Mira is evolving from a fertility-focused tool into a full-stack women’s health platform, integrating hormone testing, lifestyle guidance, and doctor collaboration.
The company emphasizes user autonomy, helping women take control of their health with personalized action plans and transparent, science-backed data.
Mira is working with universities and doctors to advance research and is pursuing integration into clinical protocols and employer wellness programs.
A new product, Ultra-Fort, launching in August, offers a faster, more accurate single-test hormone analysis using advanced immunoassay technology.
Summary:
Mira, founded by Sylvia Kang, is a pioneering women’s health company that offers at-home hormone tracking to empower users through continuous, personalized data. Addressing unexplained infertility and the lack of accessible, actionable information, Mira provides real-time insights into key hormones like estrogen, progesterone, FSH, and others—offering a far more comprehensive view than traditional ovulation kits. The company has built one of the world’s largest continuous hormone datasets, which fuels critical research into hormone-symptom links, particularly in PCOS and menopause.
Users gain control over their health through tailored action plans, community support, and direct access to coaching and AI assistance. Mira’s growth is driven by strong consumer demand and word-of-mouth adoption among women navigating fertility and life-stage transitions. The company is expanding beyond fertility into full-spectrum women’s wellness, with plans to integrate hormone monitoring into broader health routines and clinical care.
Through partnerships with researchers, doctors, and employers, Mira aims to democratize personalized healthcare and influence medical standards. Its upcoming Ultra-Fort test offers a faster, more accurate, single-hormone kit using advanced lab technology. With a clear vision to become a central platform for women’s health across life stages, Mira combines innovation, data, and community to transform how women understand and manage their bodies.
FAQs
Mira is a home hormone tracking device that measures key female hormones like ovulation, estrogen, progesterone, and FSH through urine samples. The data is analyzed in an app, providing users with insights, trends, and personalized guidance to better understand their hormonal health.
About one-third of infertility cases are diagnosed as unexplained, meaning underlying causes are unknown. Mira helps users gain visibility into their hormone levels over time, enabling them to identify patterns, take control, and develop personalized action plans to address potential issues.
Mira supports women from fertility and conception through menopause and postpartum. It helps users manage irregular cycles, track symptoms, and understand hormonal changes across life stages, offering tailored insights and wellness recommendations.
Yes, users can interact with Mira’s AI assistant or connect with professional coaches for personalized support. These conversations help users understand their data, address concerns, and develop actionable steps for improved health.
Unlike one-line ovulation kits that offer basic, snapshot readings, Mira provides continuous, quantitative hormone data over time. This gives users a detailed, longitudinal view of their cycle, enabling more accurate tracking and better decision-making.
Mira is using its 27 million continuous hormone data points to study hormone-symptom correlations during menopause, how lifestyle changes affect fertility, and patterns in conditions like PCOS. This research informs better personalization and treatment strategies.
Chat with AI
Loading...
Pro features
Go deeper with this episode
Unlock creator-grade tools that turn any transcript into show notes and subtitle files.